Amanote Research
Register
Sign In
Hemodynamics of a New Angiotensin Antagonist, [Sar1, Thr8]A II, in Hypertensive Man
Circulation
- United States
doi 10.1161/01.cir.61.2.338
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cardiovascular Medicine
Physiology
Cardiology
Date
February 1, 1980
Authors
R J Cody
R C Tarazi
F M Fouad
E L Bravo
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related search
ME3221, a Surmountable Angiotensin AT1-Receptor Antagonist, Prevents Hypertensive Complications in Aged Stroke-Prone Spontaneously Hypertensive Rats.
The Japanese Journal of Pharmacology
Angiotensin II, Mechanotransduction, and Pulsatile Arterial Hemodynamics in Hypertension
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
Angiotensin II Antagonist Prevents Electrical Remodeling in Atrial Fibrillation
Circulation
Cardiovascular Medicine
Physiology
Cardiology
The Role of Renal Hemodynamics in the Antihypertensive Action of Mepirodipine, a New Calcium Antagonist.
Japanese Circulation Journal
The Angiotensin II AT2Receptor Is an AT1Receptor Antagonist
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
In Vitro Pharmacological Properties of KRH-594, a Novel Angiotensin II Type 1 Receptor Antagonist.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Antagonist Effect of a Receptor-Mimicking Peptide Encoded by Human Angiotensin II Complementary RNA
Hypertension
Internal Medicine
Antihypertensive Action of a New Calcium Antagonist, CV-4093 (2HCl) in Spontaneously Hypertensive Rats
Japanese Heart Journal
Clinical Usefulness of Losartan, an Angiotensin II Receptor Antagonist With a Uricosuric Effect, and the Influence of Aspirin on the Effect in Hypertensive Patients With Hyperuricemia
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
